Michelle Callegan to Ophthalmic Solutions
This is a "connection" page, showing publications Michelle Callegan has written about Ophthalmic Solutions.
Connection Strength
0.504
-
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Adv Ther. 2009 Apr; 26(4):447-54.
Score: 0.314
-
Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis. Curr Eye Res. 1994 Dec; 13(12):875-8.
Score: 0.029
-
Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet. 1994 Aug; 27(2):129-49.
Score: 0.028
-
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest Ophthalmol Vis Sci. 1994 Mar; 35(3):1033-7.
Score: 0.028
-
Ocular antivirals. Int Ophthalmol Clin. 1993; 33(4):69-80.
Score: 0.025
-
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res. 1992 Nov; 11(11):1111-9.
Score: 0.025
-
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct; 33(11):3017-23.
Score: 0.025
-
Pharmacokinetics of topically applied ciprofloxacin in rabbit tears. Jpn J Ophthalmol. 1996; 40(1):123-6.
Score: 0.008
-
The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.
Score: 0.008
-
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995 Mar; 14(3):229-34.
Score: 0.007
-
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993 May; 12(5):469-73.
Score: 0.006